fahimeh attarian

Mrs. fahimeh attarian

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2022 in Frontiers in Endocrinology
Verified
Journal Article
Open access
SJSeyed Alireza Javadinia
Seyed Alireza Javadinia
KAKimia Alizadeh
Kimia Alizadeh
MMMohammad-Shafi Mojadadi
Mohammad-Shafi Mojadadi
FNFateme Nikbakht
Fateme Nikbakht
FDFarzaneh Dashti
Farzaneh Dashti
FAfahimeh attarian
fahimeh attarian
Background: Data on the efficacy and safety of COVID-19 vaccines in patients with malignancy are immature. In this paper, we assessed the literature involving the use of COVID-19 vaccines in cancer patients and reported the seroconversion rates as the main outcome and severity of COVID-19 infection and side effects following COVID-19 vaccination as the secondary outcomes.Methods: A systematic review with meta-analysis was performed. Searches were conducted in electronic websites, databases, and journals, including Scopus, PubMed, Embase, and Web of Science from January 01, 2019, to November 30, 2021. Studies reporting data on the safety and efficacy of COVID vaccine in cancer patients using any human samples were included. The risk of bias was assessed using the NEWCASTLE-OTTAWA scale in the included studies.Results: A total of 724 articles were identified from databases, out of which 201 articles were duplicates and were discarded. Subsequently, 454 articles were excluded through initial screening of the titles and abstracts. Moreover, 41 studies did not report the precise seroconversion rate either based on the type of cancer or after injection of a second dose of COVID vaccine. Finally, 28 articles met all the inclusion criteria and were included in this systematic review. The overall seroconversion rates after receiving a second dose of COVID-19 vaccine, based on type of cancer were 88% (95% CI, 81%-92%) and 70% (95% CI, 60%-79%) in patients with solid tumors and hematologic malignancies, respectively.Conclusion: Overall, we conclude that vaccination against COVID-19 in patients with active malignancies using activated and inactivated vaccines is a safe and tolerable procedure that is also accompanied by a high efficacy.

26 September 2021 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
MNMohammad Nematshahi
Mohammad Nematshahi
DSDavood Soroosh
Davood Soroosh
MNMahboubeh Neamatshahi
Mahboubeh Neamatshahi
FAfahimeh attarian
fahimeh attarian
FRFaeze Rahimi
Faeze Rahimi
Objective: COVID-19 has been introduced by the World Health Organization as a health emergency worldwide. Up to 9% of the patients with COVID-19 may be readmitted by 2 months after discharge. This study aimed to estimate the readmission rate and identify main risk factors for readmission in these patients. In this prospective study, 416 discharged COVID patients followed up with a minimum 1 month and the readmission rate was recorded. Evaluated characteristics included time of readmission, age and sex, main symptoms of disease, result of computed tomography scan, reverse transcription polymerase chain reaction test and treatment modalities. Results: Regarding readmission, 51 patients of 416 discharged patients, was readmitted during the study period. The rate of readmission for 30 and 60 days after discharge was 7.6% and 8.1%, respectively. The median age of the readmitted patients was 67 years (IQR: 53–78). About 65% of readmitted patients had underlying disease. The most significant factor in readmission rate was related to the site of lung involvement (OR > 4). Age over 60 years, underlying disease especially diabetes (OR = 3.43), high creatinine level (≥ to 1.2 mg/dl) (OR = 2.15) were the most important predictors of readmission.

5 March 2025 in International Journal of Radiation Biology
Verified
Journal Article
Closed access
DFDanial Fazilat-Panah
Danial Fazilat-Panah
SJSeyed Alireza Javadinia
Seyed Alireza Javadinia
AMAli Shabestani Monfared
Ali Shabestani Monfared
FAfahimeh attarian
fahimeh attarian
MBMansour Babaei
Mansour Babaei
HTHamid Fallah Tafti
Hamid Fallah Tafti
Knee osteoarthritis (OA) is a prevalent chronic condition characterized by progressive damage to the articular cartilage, resulting in chronic pain, swelling, and reduced range of motion with a range of prevalence of 10-40%. This study aims to investigate the efficacy of low-dose radiation as a local treatment option for knee OA symptoms. In this prospective study, patients with confirmed OA and older than 65 years were randomly assigned to treatment and control groups. The protocol plan IRCT20160706028815N6 was registered in Iranian registry of clinical trials system. The treatment group received 3 Gy radiation over six fractions, while the control group continued routine treatment without radiation. The pain intensity and functional levels were assessed at pretreatment and each month following completion of therapy for six consecutive months by Visual Analog Scale (VAS) and the Lysholm 100-point Scale, respectively. Analgesic medication usage and performance status (PS) were also assessed. The mean age of the patients was 77 years (range 72-89). All variables including VAS pain score, Lysholm scale, PS and analgesic consumption were improved following radiation from first month to the end of assessments (p value <0.01). Results showed significant pain score improvements and enhanced joint function with no adverse effects. Findings were compared with previous studies, revealing mixed conclusions on low dose radiation therapy (LDRT) efficacy. Mechanistic hypotheses suggest LDRT may modulate inflammatory pathways. The study suggests LDRT at 3 Gy could benefit knee osteoarthritis patients and calls for further research on mechanisms of action in early-stage osteoarthritis.

30 May 2022 in Cancer Investigation
Verified
Journal Article
Closed access
DFDanial Fazilat-Panah
Danial Fazilat-Panah
HTHamid Fallah Tafti
Hamid Fallah Tafti
YRYavar Rajabzadeh
Yavar Rajabzadeh
MFMaedeh Alsadat Fatemi
Maedeh Alsadat Fatemi
NANahid Ahmadi
Nahid Ahmadi
FTFarzad Taghizadeh-Hesary
Farzad Taghizadeh-Hesary
To determine the clinical characteristics and outcomes of COVID-19 in a large cohort of new cancer patients referred to an oncology clinic in the north of Iran.During the 20-month COVID-19 pandemic...

9 September 2020
Verified
Journal Article
Open access
SSShahin Saeidinejat
Shahin Saeidinejat
NBNosrat Ghaemi Belhouri
Nosrat Ghaemi Belhouri
FAfahimeh attarian
fahimeh attarian
Background: The clinical suspicion of Congenital Hypothyroidism (CH) is identified by abnormal results in the first test of Thyroid Stimulating Hormone (TSH) (5-9.9 mIU/L), and normal results in re-test (TSH<4 mIU/L). The CH has a contribution to physical and mental health. This study aimed to determine the Intelligence Quotient (IQ) score in children with suspected congenital hypothyroidism.

30 March 2021 in International Journal of Cancer Management
Verified
Journal Article
Open access
PDF file
MAMahdi Attarian
Mahdi Attarian
MAMohsen Aliakbarian
Mohsen Aliakbarian
AKAli Kermani
Ali Kermani
FAfahimeh attarian
fahimeh attarian
SASakineh Amouian
Sakineh Amouian
MNMona Najaf Najafi
Mona Najaf Najafi
Background: Recently, the predictive value of lymph node ratio (LNR, the ratio of metastatic lymph nodes to total examined lymph nodes) has been evaluated in patients with gastrointestinal malignancies, including pancreatic cancer. However, there is not enough evidence about the prognostic value of this factor. Objectives: We aimed at determining the value of LNR in predicting the survival of patients who have undergone the Whipple procedure. Methods: This cohort study was performed on 96 patients with pancreatic cancer undergoing the Whipple procedure during 2014 - 2019. Demographic, clinical, and pathological data of the patients were extracted from their records and patients' survival status was determined through follow-up. LNR and its effect on survival was calculated using the Cox model. Results: Of the 96 eligible patients, 51 (53.13%) were men. The mean age of the patients was 57.1 ± 14.1 (range: 19 - 82) years. The median total lymph nodes examined was 7 (range: 1 - 27), and no metastatic lymph nodes were found in 57 (59.37%) patients. The median involved lymph nodes and LNR were 2 and 0.17, respectively. Patients with LNR > 0.20 had the lowest 1 and 3-year survival rates. Age (P = 0.04), surgical radial margin (P = 0.001), lymph node status (N0, N1) (P = 0.01), and LNR (P = 0.01) were the most important prognostic factors for survival. Conclusions: LNR is a valuable indicator that can be used in patients with lymph node involvement as a prognostic factor for poor survival after the Whipple procedure. The lowest 1, 3, and 5-year survival rates were seen in patients with LNR > 0.20.